Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

GLS-409, a Synergistic Inhibitor of Both P2Y 1 and P2Y 12 : Efficacy in a Canine Model of Recurrent Coronary Thrombosis and Reversibility of Human Platelet Inhibition

Elena Smolensky Koganov, PhD, Alan D Michelson, MD, Ivan B Yanachkov, PhD, Milka I Yanachkova, PhD, George E Wright, PhD, Karin Przyklenk, PhD, Andrew L Frelinger, III, PhD

Blood (2017) 130 (Supplement 1): 630.

https://doi.org/10.1182/blood.V130.Suppl_1.630.630

Published: 2017

Journal Articles

Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways

Florian Beck, Jörg Geiger, Stepan Gambaryan, Johannes Veit, Marc Vaudel, Peter Nollau, Oliver Kohlbacher, Lennart Martens, Ulrich Walter, Albert Sickmann, René P. Zahedi

Blood (2014) 123 (5): e1–e10.

https://doi.org/10.1182/blood-2013-07-512384

Published: 2014

Includes: Supplemental data

Journal Articles

Pharmacodynamics of Platelet Inhibition with Aspirin: Feasibility for Detection of Suboptimal Platelet Inhibition

Jordan Schaefer, MD, John Davis, B.S., Kenneth A. Schwartz, MD

Blood (2012) 120 (21): 4361.

https://doi.org/10.1182/blood.V120.21.4361.4361

Published: 2012

Journal Articles

Effects of Strong P2Y12 Receptor Inhibition by Prasugrel on Platelet Inhibition During Endotoxemia: A Randomized Controlled Trial

Alexander O Spiel, MD, Ulla Derhaschnig, MD, Petra Jilma-Stohlawetz, MD, Bernd Jilma, MD

Blood (2011) 118 (21): 1245.

https://doi.org/10.1182/blood.V118.21.1245.1245

Published: 2011

Journal Articles

Amount of Platelet Inhibition Produced When Initiating Aspirin Therapy: Comparison of Two Doses 81 Vs. 325

Kenneth A. Schwartz, MD, Simona Chivu, MD, John Davis, B.S.

Blood (2011) 118 (21): 1250.

https://doi.org/10.1182/blood.V118.21.1250.1250

Published: 2011

Journal Articles

Platelet Inhibition by Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel In Patients with Acute Myocardial Infarction According to Cytochrome P450 2C19 Genotype

In-Suk Kim, MD, PhD, Young-Hoon Jeong, Arum Kim, Gyeong-Won Lee

Blood (2010) 116 (21): 3322.

https://doi.org/10.1182/blood.V116.21.3322.3322

Published: 2010

Journal Articles

Proteomics unravels platelet function

Karlheinz Peter

Blood (2010) 115 (20): 4008–4009.

https://doi.org/10.1182/blood-2010-02-270298

Published: 2010

Journal Articles

Comprehensive Quality Management of Multiple Electrode Platelet Aggregometry.

Michael Spannagl, MD, Andrea Dick, Andreas Calatzis

Blood (2009) 114 (22): 4463.

https://doi.org/10.1182/blood.V114.22.4463.4463

Published: 2009

Journal Articles

Non-Compliance Is the Predominant Cause of Aspirin Resistance.

Kenneth A. Schwartz, MD, Dianne E. Schwartz, BS, Kimberly Barber, PhD, Matt Reeves, DVM, Anthony DeFranco, MD

Blood (2007) 110 (11): 932.

https://doi.org/10.1182/blood.V110.11.932.932

Published: 2007

Journal Articles

A new mechanism for nitric oxide– and cGMP-mediated platelet inhibition

Xiaoping Du

Blood (2007) 109 (2): 392–393.

https://doi.org/10.1182/blood-2006-10-053827

Published: 2007

Journal Articles

“Aspirin Resistance”: Low Prevalence and Assay Discordance in a Pediatric Cohort.

Donald L. Yee, MD, Bogdan Dinu, MD, Jun Teruya, MD, DSc, Paul F. Bray, MD, Lisa Bomgaars, MD

Blood (2006) 108 (11): 886.

https://doi.org/10.1182/blood.V108.11.886.886

Published: 2006

Journal Articles

Effects of Non-Steroidal Anti-Inflammatory Drugs and COX-2 Inhibitors on Aspirin-Induced Platelet Inhibition.

Carol Sun, B.S., Angela Bergeron, B.S., Jennifer Wood, Ph.D., Jo Ellen Schweinle, M.D., Frank L. Lanza, M.D., Byron Cryer, M.D., Jin-Fei Dong, M.D., Ph.D.

Blood (2004) 104 (11): 531.

https://doi.org/10.1182/blood.V104.11.531.531

Published: 2004

Journal Articles

Does cGMP mediate platelet inhibition or stimulation?

Wolfgang Siess

Blood (2004) 103 (7): 2435–2436.

https://doi.org/10.1182/blood-2004-01-0239

Published: 2004

Journal Articles

A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans

Zhenyu Li, Jasna Ajdic, Martin Eigenthaler, Xiaoping Du

Blood (2003) 101 (11): 4423–4429.

https://doi.org/10.1182/blood-2002-10-3210

Published: 2003

NARROW

GLS-409, a Synergistic Inhibitor of Both P2Y 1 and P2Y 12 : Efficacy in a Canine Model of Recurrent Coronary Thrombosis and Reversibility of Human Platelet Inhibition

Time-resolved characterization of cAMP/PKA-dependent signaling reveals that platelet inhibition is a concerted process involving multiple signaling pathways

Pharmacodynamics of Platelet Inhibition with Aspirin: Feasibility for Detection of Suboptimal Platelet Inhibition

Effects of Strong P2Y12 Receptor Inhibition by Prasugrel on Platelet Inhibition During Endotoxemia: A Randomized Controlled Trial

Amount of Platelet Inhibition Produced When Initiating Aspirin Therapy: Comparison of Two Doses 81 Vs. 325

Platelet Inhibition by Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel In Patients with Acute Myocardial Infarction According to Cytochrome P450 2C19 Genotype

Proteomics unravels platelet function

Comprehensive Quality Management of Multiple Electrode Platelet Aggregometry.

Non-Compliance Is the Predominant Cause of Aspirin Resistance.

A new mechanism for nitric oxide– and cGMP-mediated platelet inhibition

“Aspirin Resistance”: Low Prevalence and Assay Discordance in a Pediatric Cohort.

Effects of Non-Steroidal Anti-Inflammatory Drugs and COX-2 Inhibitors on Aspirin-Induced Platelet Inhibition.

Does cGMP mediate platelet inhibition or stimulation?

A predominant role for cAMP-dependent protein kinase in the cGMP-induced phosphorylation of vasodilator-stimulated phosphoprotein and platelet inhibition in humans

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only